Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,877.64
+526.55
(+1.05%)
BRANDS
Meet one of the UK’s largest unknown start-ups
Video editing platform Veed has grown to 10 million users
InMed Pharmaceuticals Inc. (INM)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2420
-0.0219
(-8.30%)
At close: 04:00PM EDT
0.2404
-0.00
(-0.66%)
After hours:
05:04PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
5,487
4,136
1,089
0
0
Cost of revenue
3,379
2,733
545.889
0
-
Gross profit
2,108
1,403
543.546
0
-
Operating expenses
Research development
3,404
3,732
7,283
5,338
5,811
Selling general and administrative
5,485
5,848
6,867
4,479
3,227
Total operating expenses
9,103
9,782
14,335
9,938
9,151
Operating income or loss
-6,995
-8,379
-13,792
-9,938
-9,151
Interest expense
-
-
0
360.35
0
Total other income/expenses net
39.818
-48.175
-4,904
79.527
82.187
Income before tax
-6,348
-7,935
-18,600
-10,203
-8,939
Income tax expense
3.3
13.1
0
-
-
Income from continuing operations
-6,351
-7,948
-18,600
-10,203
-8,939
Net income
-6,351
-7,948
-18,600
-10,203
-8,939
Net income available to common shareholders
-6,351
-7,948
-18,600
-10,203
-8,939
Basic EPS
0.05
-3.25
-1.33
-37.96
-42.75
Diluted EPS
0.05
-3.25
-1.33
-37.96
-42.75
Basic average shares
3,064
2,448
14,021
268.793
208.828
Diluted average shares
3,064
2,448
14,021
268.793
208.828
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.